The complement receptor of the immunoglobulin superfamily (CRIg)+ TAMs in human ovarian cancer is similar to murine Tim-4+ TAMs in terms of transcriptional levels, metabolic effects, and functional roles. Here, VSIG4 is linked to ovarian cancer.